Kairos Pharma's three largest insider shareholders as of September 09, 2026 are Ramachandran Murali (Vp Of Research And Development, 299.53K shares), Doug Samuelson (Chief Financial Officer, 293.04K shares), John S Yu (Ceo And Chairman, 230.10K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ramachandran Murali | Vp Of Research And Development | 299,529 | 0 | 299,529 | 35.2% | 26 Nov, 2025 |
| 2 | Doug Samuelson | Chief Financial Officer | 293,039 | 0 | 293,039 | 34.4% | 26 Nov, 2025 |
| 3 | John S Yu | Ceo And Chairman | 230,105 | 0 | 230,105 | 27.0% | 26 Nov, 2025 |
| 4 | Hansoo Michael Keyoung | Director | 29,084 | 0 | 29,084 | 3.4% | 26 Nov, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 16 Sep, 2025 | Hansoo Michael Keyoung | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Oct, 2025 | Doug Samuelson | Chief Financial Officer | Acquired A | 152,672 | $0.00 | $0 | 293,039 | Direct |
| 08 Oct, 2025 | Doug Samuelson | Chief Financial Officer | Acquired A | 152,672 | $0.00 | $0 | 293,039 | Direct |
| 16 Sep, 2025 | Hansoo Michael Keyoung | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Oct, 2025 | Ramachandran Murali | Vp Of Research And Development | Acquired A | 152,672 | $0.00 | $0 | 299,529 | Direct |
| 08 Oct, 2025 | John S Yu | Ceo And Chairman | Acquired A | 190,840 | $0.00 | $0 | 230,105 | Direct |
| 08 Oct, 2025 | Ramachandran Murali | Vp Of Research And Development | Acquired A | 152,672 | $0.00 | $0 | 299,529 | Direct |
| 08 Oct, 2025 | Doug Samuelson | Chief Financial Officer | Acquired A | 152,672 | $0.00 | $0 | 293,039 | Direct |
| 08 Oct, 2025 | John S Yu | Ceo And Chairman | Acquired A | 190,840 | $0.00 | $0 | 230,105 | Direct |
| 08 Oct, 2025 | John S Yu | Ceo And Chairman | Acquired A | 190,840 | $0.00 | $0 | 230,105 | Direct |
| 08 Oct, 2025 | Ramachandran Murali | Vp Of Research And Development | Acquired A | 152,672 | $0.00 | $0 | 299,529 | Direct |
| 16 Sep, 2025 | Hansoo Michael Keyoung | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 08 Oct, 2025 | Hansoo Michael Keyoung | Director | Acquired A | 19,084 | $0.00 | $0 | 29,084 | Direct |
| 08 Oct, 2025 | Hansoo Michael Keyoung | Director | Acquired A | 19,084 | $0.00 | $0 | 29,084 | Direct |
| 08 Oct, 2025 | Hansoo Michael Keyoung | Director | Acquired A | 19,084 | $0.00 | $0 | 29,084 | Direct |
| 01 Jan, 2025 | John S Yu | Ceo And Chairman | Acquired A | 14,000 | $0.00 | $0 | 5,355,838 | Direct |
| 01 Jan, 2025 | John S Yu | Ceo And Chairman | Acquired A | 14,000 | $0.00 | $0 | 5,355,838 | Direct |
| 01 Jan, 2025 | Ramachandran Murali | Vp Of Research And Development | Acquired A | 14,000 | $0.00 | $0 | 147,057 | Direct |
| 01 Jan, 2025 | Ramachandran Murali | Vp Of Research And Development | Acquired A | 14,000 | $0.00 | $0 | 147,057 | Direct |
| 01 Jan, 2025 | John S Yu | Ceo And Chairman | Acquired A | 14,000 | $0.00 | $0 | 5,355,838 | Direct |